Local MedTech Boom: India Manufactures MRI and CT Scans
The medical devices PLI scheme has catalyzed domestic production of high-end diagnostic and therapeutic technologies across India. Historically, Indian healthcare facilities imported over seventy percent of their specialized clinical equipment. Consequently, domestic hospitals faced steep capital expenditures, high servicing costs, and significant supply delays. However, recent regulatory initiatives now foster domestic engineering of critical devices such as MRI machines, CT scanners, and heart valves. Therefore, healthcare providers can access vital technologies more efficiently, which strengthens the wider Indian medical ecosystem.
How the Medical Devices PLI Scheme Transforms Local Manufacturing
The Department of Pharmaceuticals launched this strategic initiative with a financial outlay of 3,420 crore rupees. Furthermore, the program offers a five percent incentive on incremental sales of eligible domestic devices. As a result, manufacturers have commenced domestic production of 57 medical devices that healthcare providers previously imported. Specifically, these products span essential clinical categories, including cancer radiotherapy, advanced radiology, renal care, and cardiovascular implants. Global technology leaders like GE Healthcare, Siemens, and Philips now expand their manufacturing footprints in India. In addition, these investments accelerate technology transfer and elevate local engineering standards.
Clinical Impact on Diagnostics and Patient Care
Clinicians require dependable and timely access to cutting-edge diagnostic equipment to treat complex ailments. Previously, procurement delays for linear accelerators and cath labs often hindered oncology and interventional cardiology services. Moreover, imported replacement parts routinely disrupted hospital workflow during crucial patient procedures. Fortunately, local manufacturing minimizes these procurement bottlenecks. In addition, domestic production lowers equipment costs by ten to thirty percent compared to foreign alternatives. Consequently, regional hospitals and tier-two diagnostic centers can expand advanced imaging services. Ultimately, this increased availability allows clinicians to diagnose and manage life-threatening diseases much faster.
Strengthening Healthcare Infrastructure and Affordability
Beyond high-end imaging, the scheme strongly supports implant manufacturing, including prosthetic heart valves and vascular stents. Because cardiac disease represents a major health burden in India, domestic supply chains ensure reliable product availability. Furthermore, competitive local production reduces out-of-pocket expenses for underserved patients. Domestic production also fosters specialized training for biomedical engineers, clinical technicians, and support staff. Meanwhile, medical device parks supply shared testing and sterilization infrastructure to sustain stringent regulatory standards. Thus, clinicians can confidently adopt Indian-made devices while maintaining uncompromised safety and efficacy.
Frequently Asked Questions
Q1: What is the main objective of the medical devices PLI scheme?
The scheme encourages domestic production of high-end medical equipment, reduces import reliance, and attracts major global investments into India's healthcare manufacturing ecosystem.
Q2: Which medical devices are now manufactured domestically under the initiative?
Manufacturers now produce MRI machines, CT scanners, linear accelerators, cath labs, mammography units, C-arms, ultrasound systems, and prosthetic heart valves locally.
Q3: How does this initiative benefit Indian doctors and healthcare facilities?
It reduces equipment procurement costs, speeds up maintenance, prevents supply chain disruptions, and broadens patient access to high-precision diagnostic and therapeutic care.
References
- Medical devices PLI scheme drives local output of MRI, CT scanners, heartvalves: Centre - ETHealthworld
- Press Information Bureau, Ministry of Chemicals and Fertilizers. High Precision Medical Instruments (July 2026).
- Press Information Bureau, Ministry of Chemicals and Fertilizers. Manufacturing and innovation of medical devices (December 2025).
